VidavoATH:VIDAVO 90 FCF Margin % is 14.66% as of Dec. 2025. GuruFocus rates ATH:VIDAVO with a GF Score™ of 90/100 and a GF Value™ of €8.46 (Fairly Valued). The stock has 6 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Vidavo ranks worse than 62.56% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Vidavo's Free Cash Flow for the
six
months ended in Dec. 2025 was €0.30 Mil. Vidavo's Revenue for the
six
months ended in Dec. 2025 was €2.05 Mil. Therefore, Vidavo's FCF Margin % for the quarter that ended in Dec. 2025 was 14.66%.
The historical rank and industry rank for Vidavo's FCF Margin % or its related term are showing as below:
ATH:VIDAVO'
s FCF Margin % Range Over the Past 10 Years
Min: -66.43 Med: -1.88 Max: 102.06
Current: -1.25
During the past 13 years, the highest FCF Margin % of Vidavo was 102.06%. The lowest was -66.43%. And the median was -1.88%.
ATH:VIDAVO's FCF Margin % is ranked worse than 62.56% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: 3.1
vs ATH:VIDAVO: -1.25
Vidavo FCF Margin % Related Terms
Vidavo FCF Margin % Historical Data
* Premium members only.
The historical data trend for Vidavo's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ATH:VIDAVO vs VEEV, BTSG, TEM: FCF Margin % Comparison
For the Health Information Services subindustry, Vidavo's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vidavo FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Vidavo's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Vidavo's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vidavo (ATH:VIDAVO) has a FCF Margin % of 14.66% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vidavo and its competitors. According to the industry distribution chart, Vidavo ranks #416 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 62.6%.
Is Vidavo's FCF Margin % too high?
Vidavo's current FCF Margin % is 14.66%. The Healthcare Providers & Services industry median FCF Margin % is 3.10. Vidavo's value of 14.66% is 372.9% above this industry median. Based on the distribution chart, Vidavo ranks #416 out of 665 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Vidavo has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Vidavo's FCF Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Vidavo ranks #416 out of 665 companies for FCF Margin %. This places Vidavo in the lower half of its industry. The industry median FCF Margin % is 3.10. Vidavo's value of 14.66% is 372.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.10, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vidavo's current FCF Margin % of 14.66% is 372.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vidavo and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vidavo's current FCF Margin % is 14.66%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vidavo stock overvalued right now?
Based on GuruFocus' analysis, Vidavo (ATH:VIDAVO) is currently considered Fairly Valued. The stock's GF Value™ is €8.46, compared to a current price of €8.60 — trading 1.7% above its estimated fair value. The current FCF Margin % is 14.66% and 372.9% above the Healthcare Providers & Services industry median of 3.10. Vidavo's overall GF Score™ is 90/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Vidavo (ATH:VIDAVO), the current FCF Margin % is 14.66% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vidavo (ATH:VIDAVO) Overvalued in 2026?
Based on GuruFocus' analysis, Vidavo stock appears to be overvalued.
The current stock price of €8.60 is trading 1.7% above its estimated GF Value™ of €8.46.
GuruFocus considers Vidavo to be Fairly Valued.
Key valuation signals for ATH:VIDAVO:
FCF Margin %: 14.66%
GF Value™: €8.46 vs. price of €8.60 (1.7% above fair value)
Industry Position: 372.9% above the Healthcare Providers & Services median (#416 of 665)
No single metric tells the full story. See the ATH:VIDAVO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vidavo SA develops mobile applications that help citizens on-the-move and medical professionals manage health and wellness. The company serves health and social care providers, policymakers, insurance companies, ICT firms seeking differentiation, patients, telecom operators, and other health-related stakeholders. Its solutions include vida24, vidatrack, and vidahome.
90GF Score
Get the complete analysis for ATH:VIDAVO
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ATH:VIDAVO has been successfully added to your 
